Business Development

"Our focus is getting the product on the market, and we have all the capabilities in-house to register and commercialize innovative pharmaceuticals in Canada."

- Jeff Skinner, Vice President, Business Development

Valeo Pharma Inc. has built its business on a foundation of strong partnerships with International Pharmaceutical Companies. We look for partners with world class R&D and state of the art manufacturing facilities to expand our own internal capabilities. By having all resources and expertise under management to register and market innovative products, we have the flexibility and know-how to maximize the potential of our partnerships.

While the decision is always driven by the product, natural areas of expertise and focus include:

  • Rare and Orphan Diseases
  • Oncology
  • Neurodegenerative Diseases
  • Pain Management, including Narcotics
  • Anti-Infectives

Valeo Pharma's portfolio consists of innovative products that create more choice for the Canadian specialist, and ultimately, improves the lives of Canadian patients. If you have innovative products registered or approved in Territories outside of Canada, or in late Phase III Clinical studies, and are interested in partnering for launch in Canada, please contact us to learn more about our capabilities.


If you are interested in discussing potential business opportunities, please contact

Jeffrey Skinner - Vice President, Business Development
skinner@valeopharma.com